MIT Enterprise Forum: Startup Clinic: Life Sciences Startups
Come and Hear from two life sciences startups out of MIT:Firefly Bioworks and Lantos Technologies
Cases: Firefly BioWorks, Inc. www.fireflybio.com
Daniel Pregibon, PhD, President, Co-founder
Davide Marini, PhD/MBA, Co-founder
Firefly BioWorks is devoted to developing innovative molecular diagnostic assays to help researchers and clinicians reduce uncertainty in their decision making. Theirr core technology platform is a method for performing rapid and multiplexed biomolecules detection that allows a combination of sensitivity, specificity, reliability, speed and cost not available from any existing alternative. The technology was born in the laboratory of Prof. Patrick Doyle at MIT and utilizes barcoded gel microparticles that are rapidly custom-synthesized using a ground-breaking combination of microfluidics and photolithography. Firefly BioWorks goal is to become a leading developer and provider of clinical instruments and diagnostic tests in the areas of cancer, infectious diseases and multidrug resistance.
Lantos Technologies, Inc.
Shahid Azim, Founder & CEO
Panelists:
Greg Erman, Medical Technology Entrepreneur
Mirena Bagur, President, CONTeXO - Content. Context. Connections
William C. Mills III is an independent venture capitalist and is currently a board member of Ascension Health Ventures and Stereotaxis, Inc.
Moderator:
Marc Rioult, MIT Technology Licensing Office










